Clinical Trial Update: Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo [NA]

View source ↗

Summary

A completed clinical trial comparing naltrexone/bupropion to placebo for binge eating disorder in obesity; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Naltrexone/Bupropion (Naltrexone and bupropion)

Snippet

Sponsor: Yale University | Conditions: Binge Eating Disorder | NA | Status: COMPLETED | Results posted: 2017-12-22